Denton Nursing: Medication Changes Hidden from Families - MD
Staff member 34 lost her job on December 10, 2024, according to her employee file. The termination notice cited her failure to take "immediate action" on November 28 when several staff members reported issues with resident 12.
The Assistant Director of Nursing confirmed during a September 3 interview that the nurse had not notified the resident's physician in a timely manner about the condition change.
But the staffing violation was just part of a broader pattern of communication failures that inspectors documented during their complaint investigation.
Resident 16, who had been living at the facility since August 2023, never had his family notified about a series of psychiatric medication changes that began in March. The resident had dementia, heart disease, atrial fibrillation, and other conditions requiring careful monitoring.
On March 6, 2025, doctors changed his anti-psychotic medication Risperdal from 0.25 mg once daily to twice daily. No family notification was documented in his medical record.
Two weeks later, on March 19, physicians added a new anti-anxiety medication, Buspar 5 mg twice daily. Again, no family notification.
The medication increases continued through April. On April 16, the Risperdal dose doubled to 0.5 mg twice daily. On April 25, the Buspar frequency increased from twice daily to three times daily. On April 30, the Risperdal dose jumped again to 0.75 mg twice daily.
Five separate medication changes over two months. No family notifications for any of them.
The Assistant Director of Nursing reviewed the medical record during her September 4 interview with inspectors and confirmed the missing notifications. She told inspectors she thought the communication problem existed before she started working at the facility but believed it was no longer an issue.
The inspection findings contradicted her assessment.
Federal regulations require nursing homes to notify residents' responsible parties about significant medication changes, particularly for psychiatric drugs that can cause serious side effects in elderly patients with dementia. Anti-psychotic medications like Risperdal carry FDA black box warnings about increased death risk in dementia patients.
The facility's failures left families in the dark about critical treatment decisions affecting their loved ones. Resident 16's family had no knowledge their relative was receiving escalating doses of powerful psychiatric medications over a two-month period.
The communication breakdown extended beyond medication changes. The complaint that triggered the inspection alleged broader problems with family notification when treatment plans changed.
Inspectors classified the violations as causing minimal harm or potential for actual harm to a few residents. But the pattern of hidden medication increases and delayed physician notifications suggests systemic problems with basic care coordination.
The fired nurse's case illustrated how communication failures could escalate quickly. When multiple staff members reported concerns about a resident's condition on November 28, the licensed practical nurse failed to contact the physician promptly. The facility waited nearly two weeks to terminate her employment.
Meanwhile, resident 16's family remained unaware that their relative's psychiatric medication doses had tripled over eight weeks. The Risperdal increase from 0.25 mg daily in February to 1.5 mg daily by April 30 represented a six-fold dose escalation with no family input or notification.
The Assistant Director of Nursing's belief that communication problems were resolved proved incorrect when inspectors found no documentation of family notifications for any of the five medication changes they reviewed.
Both violations occurred at a facility responsible for coordinating complex medical care for vulnerable residents with multiple chronic conditions. Resident 16's combination of dementia, heart disease, and atrial fibrillation required careful medication management and family involvement in treatment decisions.
Instead, the family discovered their relative's medication changes only when federal inspectors arrived to investigate complaints about the facility's communication practices.
The inspection revealed a facility where nurses failed to call doctors about condition changes and administrators failed to notify families about psychiatric drug increases that could affect their loved ones' behavior, cognition, and safety.
Resident 16 continued living at the facility as of the September inspection, receiving 1.5 mg of Risperdal daily and Buspar three times daily, medications his family learned about only through the federal investigation.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Denton Nursing and Rehab from 2025-09-04 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: Official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).
Editorial process: AI-synthesized regulatory data, reviewed for accuracy by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: June 21, 2026 · Our methodology
DENTON NURSING AND REHAB in DENTON, MD was cited for violations during a health inspection on September 4, 2025.
Staff member 34 lost her job on December 10, 2024, according to her employee file.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.